CRISIL reaffirms 20 Microns at CRISIL A
20 Microns (20MICRONS) said CRISIL has reaffirmed its credit rating at CRISIL A, covering facilities or instruments of about ₹117 crore. The company is valued at about ₹568 crore.
What happened
In a filing with the BSE on 30 October 2026 at 12:27 PM, 20 Microns (20MICRONS) said that CRISIL has reaffirmed its credit rating at CRISIL A, covering facilities or instruments of about ₹117 crore.
Company snapshot
20 Microns is a micro-cap company, with a market value of about ₹568 crore.
The stock last traded at ₹161, against a 52-week range of ₹129.6–₹237.4 (32.2% below the high).
Before this filing the shares had moved −26.0% over the month and −19.9% over three months. Average daily turnover over the last 20 sessions was about ₹2.59 crore.
Promoters held 45.04% at the end of Q2 FY27. Foreign institutions owned 1.03% and domestic institutions 0.07%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 231 | 17.4 | 4.92 |
| Q3 FY26 | 215 | 15 | 4.24 |
| Q4 FY26 | 261 | 17.6 | 4.99 |
| Q1 FY27 | 245 | 17.8 | 5.04 |
| Q2 FY27 | 238 | 13.7 | 3.87 |
What history shows
This is not the company's first credit rating disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Market-wide, 1,362 credit rating filings with an impact score of 50 or more saw an average next-day move of +0.1%, with 46% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Whether other agencies take a similar view on the company's credit.
In the news
Recent coverage elsewhere (links open the original publisher):
- 20 Microns Ltd Sept-Quarter Consol Net Profit 136.7 Mln Rupees
- 20 Microns schedules Q2FY27 earnings call for October 30, 2026
- 20 Microns Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026
- 20 Microns Q2 Revenue Rises to ₹240 Cr as Net Profit Drops to ₹13.7 Cr YoY
- 20 Microns (NSE:20MICRONS) Ticks All The Boxes When It Comes To Earnings Growth
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.